| 5-R21-EB032112-03 |
A Directed Evolution Approach to Affinity-Based Protein Delivery |
Marian Hettiaratchi |
University of Oregon |
| 5-R21-EB031347-03 |
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2 |
David Wilson |
Johns Hopkins University |
| 5-R03-EB033487-02 |
Cationic Silyl-lipids for Enhanced Delivery of Anti-viral RNA Therapeutics |
Annaliese Franz |
University of California at Davis |
| 5-R01-EB031082-03 |
Localized immunotherapy using alum-binding therapeutics |
Darrell Irvine |
Massachusetts Institute of Technology |
| 5-R03-EB033704-02 |
Supramolecular polymers for targeted protein degradation |
Tristan Clemons |
University of Southern Mississippi |
| 1-R21-EB029677-01 |
Tension-Sensitive Drug Release System to Enhance Targeting Selectivity |
Yun Chen |
Johns Hopkins University |
| 5-R21-EB032240-02 |
Zwitterionic Dendrimer-modified PEG for Protein Conjugation |
Chong Cheng |
State University of New York at Buffalo |
